These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1056 related items for PubMed ID: 31408782

  • 21. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells.
    Shen Y, Li M, Liu T, Liu J, Xie Y, Zhang J, Xu S, Liu H.
    Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813
    [Abstract] [Full Text] [Related]

  • 22. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T, Geng T, Md A, Banerjee P, Wang B.
    Colloids Surf B Biointerfaces; 2019 Apr 01; 176():185-193. PubMed ID: 30616109
    [Abstract] [Full Text] [Related]

  • 23. A facile route for rapid synthesis of hollow mesoporous silica nanoparticles as pH-responsive delivery carrier.
    Xu H, Zhang H, Wang D, Wu L, Liu X, Jiao Z.
    J Colloid Interface Sci; 2015 Aug 01; 451():101-7. PubMed ID: 25890118
    [Abstract] [Full Text] [Related]

  • 24. Fabricating a PDA-Liposome Dual-Film Coated Hollow Mesoporous Silica Nanoplatform for Chemo-Photothermal Synergistic Antitumor Therapy.
    Fan C, Wang X, Wang Y, Xi Z, Wang Y, Zhu S, Wang M, Xu L.
    Pharmaceutics; 2023 Apr 03; 15(4):. PubMed ID: 37111615
    [Abstract] [Full Text] [Related]

  • 25. Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles.
    Chen L, She X, Wang T, He L, Shigdar S, Duan W, Kong L.
    Nanoscale; 2015 Sep 07; 7(33):14080-92. PubMed ID: 26242620
    [Abstract] [Full Text] [Related]

  • 26. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q, Zhao H, Li D, Liu L, Du S.
    Colloids Surf B Biointerfaces; 2017 Jan 01; 149():138-145. PubMed ID: 27750088
    [Abstract] [Full Text] [Related]

  • 27. Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.
    Bafkary R, Ahmadi S, Fayazi F, Karimi M, Fatahi Y, Ebrahimi SM, Atyabi F, Dinarvand R.
    Daru; 2020 Jun 01; 28(1):171-180. PubMed ID: 32006342
    [Abstract] [Full Text] [Related]

  • 28. Albumin-MnO2 gated hollow mesoporous silica nanosystem for modulating tumor hypoxia and synergetic therapy of cervical carcinoma.
    Fang J, Wang Q, Yang G, Xiao X, Li L, Yu T.
    Colloids Surf B Biointerfaces; 2019 Jul 01; 179():250-259. PubMed ID: 30978612
    [Abstract] [Full Text] [Related]

  • 29. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
    Nasri N, Saharkhiz S, Dini G, Yousefnia S.
    Int J Pharm; 2023 Dec 15; 648():123606. PubMed ID: 37972671
    [Abstract] [Full Text] [Related]

  • 30. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
    Niu S, Zhang X, Williams GR, Wu J, Gao F, Fu Z, Chen X, Lu S, Zhu LM.
    Acta Biomater; 2021 May 15; 126():408-420. PubMed ID: 33731303
    [Abstract] [Full Text] [Related]

  • 31. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
    Akbarzadeh M, Babaei M, Abnous K, Taghdisi SM, Peivandi MT, Ramezani M, Alibolandi M.
    Int J Pharm; 2019 Oct 30; 570():118645. PubMed ID: 31465835
    [Abstract] [Full Text] [Related]

  • 32. Folic acid-modified Prussian blue/polydopamine nanoparticles as an MRI agent for use in targeted chemo/photothermal therapy.
    Lin X, Cao Y, Li J, Zheng D, Lan S, Xue Y, Yu F, Wu M, Zhu X.
    Biomater Sci; 2019 Jul 01; 7(7):2996-3006. PubMed ID: 31111139
    [Abstract] [Full Text] [Related]

  • 33. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT, To KK, Chow AH.
    Colloids Surf B Biointerfaces; 2016 Mar 01; 139():249-58. PubMed ID: 26724466
    [Abstract] [Full Text] [Related]

  • 34. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles.
    Gao Y, Chen Y, Ji X, He X, Yin Q, Zhang Z, Shi J, Li Y.
    ACS Nano; 2011 Dec 27; 5(12):9788-98. PubMed ID: 22070571
    [Abstract] [Full Text] [Related]

  • 35. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
    Gautam M, Thapa RK, Poudel BK, Gupta B, Ruttala HB, Nguyen HT, Soe ZC, Ou W, Poudel K, Choi HG, Ku SK, Yong CS, Kim JO.
    Acta Biomater; 2019 Apr 01; 88():448-461. PubMed ID: 30818051
    [Abstract] [Full Text] [Related]

  • 36. EpCAM aptamer-functionalized polydopamine-coated mesoporous silica nanoparticles loaded with DM1 for targeted therapy in colorectal cancer.
    Li Y, Duo Y, Bao S, He L, Ling K, Luo J, Zhang Y, Huang H, Zhang H, Yu X.
    Int J Nanomedicine; 2017 Apr 01; 12():6239-6257. PubMed ID: 28894364
    [Abstract] [Full Text] [Related]

  • 37. Multifunctional PEG modified DOX loaded mesoporous silica nanoparticle@CuS nanohybrids as photo-thermal agent and thermal-triggered drug release vehicle for hepatocellular carcinoma treatment.
    Wu L, Wu M, Zeng Y, Zhang D, Zheng A, Liu X, Liu J.
    Nanotechnology; 2015 Jan 16; 26(2):025102. PubMed ID: 25517859
    [Abstract] [Full Text] [Related]

  • 38. Sterically Stabilised Polymeric Mesoporous Silica Nanoparticles Improve Doxorubicin Efficiency: Tailored Cancer Therapy.
    Moodley T, Singh M.
    Molecules; 2020 Feb 08; 25(3):. PubMed ID: 32046364
    [Abstract] [Full Text] [Related]

  • 39. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.
    Tambe P, Kumar P, Paknikar KM, Gajbhiye V.
    Int J Nanomedicine; 2018 Feb 08; 13():7669-7680. PubMed ID: 30538451
    [Abstract] [Full Text] [Related]

  • 40. Mitochondria-Targeting Polydopamine Nanoparticles To Deliver Doxorubicin for Overcoming Drug Resistance.
    Li WQ, Wang Z, Hao S, He H, Wan Y, Zhu C, Sun LP, Cheng G, Zheng SY.
    ACS Appl Mater Interfaces; 2017 May 24; 9(20):16793-16802. PubMed ID: 28481505
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.